GlobeNewswire
-
Sevaro Health Unveils New Brand as It Grows Beyond Neurology to Expand Access to Tech-Enabled Specialty Care
19/11/2026 -
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Atopic Dermatitis
19/11/2026 -
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
19/11/2026 -
Alpha Tau Announces Third Quarter 2026 Financial Results and Provides Corporate Update
19/11/2026 -
Standard BioTools Stockholders Approve All Proposals Related to Merger with Treeline Biosciences and Sale of Mass Cytometry Business
19/11/2026 -
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/11/2026 -
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
19/11/2026 -
Assurion Labs Sets a Verified-Lot Standard for Research Peptides: ≥99% HPLC Purity, Peptide Net Content and Comprehensive Screening on Every Lot
19/11/2026 -
SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026
19/11/2026 -
Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
19/11/2026 -
GATC Health Joins Bipartisan Panel at U.S. Capitol on the Future of Human-Relevant Drug Development
19/11/2026 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
19/11/2026 -
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
19/11/2026 -
Clearmind Medicine Expands PTSD Patent Portfolio with Hong Kong Patent Application Publication
19/11/2026 -
Trading by management and close relations of management
19/11/2026 -
Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall population
19/11/2026 -
Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access
19/11/2026 -
New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment
19/11/2026 -
Bluesight Tracks 340B Dollars from Invoice to Rebate as 2027 Brings New Financial and Operational Challenges
19/11/2026
Pages